SCHEMBL6048545

SCHEMBL6048545

CN(C)Cc1ccccc1-c1ccc(Cl)c(O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.48
CYP2D6 P10635 5/20 0.48
CYP3A4 P08684 4/20 0.48
CLK4 Q9HAZ1 2/20 0.48
SLC6A4 P31645 8/20 0.48
SLC6A2 P23975 7/20 0.48
SLC6A3 Q01959 7/20 0.48
ALDH1A1 P00352 2/20 0.46
CYP2C19 P33261 2/20 0.46
HSD17B10 Q99714 1/20 0.46
ITGB1 P05556 1/20 0.45
ITGA4 P13612 1/20 0.45
ITGB7 P26010 1/20 0.45
HTR2A P28223 2/20 0.44
KCNH2 Q12809 1/20 0.44
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6048514 0.98 CYP1A2 (0.47) CYP1A2CYP2D6CYP3A4CLK4SLC6A4
SCHEMBL6048560 0.87 SLC6A4 (0.58) CYP1A2CYP2D6CYP3A4CLK4SLC6A4
SCHEMBL6048527 0.87 TAAR1 (0.57) CYP1A2CYP2D6CYP3A4CLK4SLC6A4
Hydrochloric Acid SCHEMBL6048509 0.86 SLC6A4 (0.56) CYP1A2CYP2D6CYP3A4CLK4SLC6A4
Hydrochloric Acid SCHEMBL6048534 0.85 TAAR1 (0.55) SLC6A4SLC6A2SLC6A3HTR2AAPP
SCHEMBL6048493 0.83 CYP3A4 (0.47) CYP1A2CYP2D6CYP3A4CLK4SLC6A4
Hydrochloric Acid SCHEMBL6048600 0.82 CYP3A4 (0.46) CYP1A2CYP2D6CYP3A4CLK4SLC6A4
SCHEMBL6048519 0.81 HTR7 (0.53) CYP1A2CYP2D6CYP3A4CLK4SLC6A4
SCHEMBL6048567 0.80 PTGS2 (0.50) CYP1A2CYP2D6CYP3A4CLK4SLC6A4
Hydrochloric Acid SCHEMBL6048520 0.80 HTR7 (0.52) CYP1A2CYP2D6CYP3A4CLK4SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202953-B1 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES GRUENENTHAL GMBH (DE) 2006-08-30 EP claimed
US-6710080-B2 ANALGESICS GRUENENTHAL GMBH (DE) 2004-03-23 US claimed
JP-2003506426-A 2003-02-18 JP claimed
EP-1202953-A2 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES Grünenthal GmbH (DE) 2002-05-08 EP claimed
WO-2001010816-A2 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES Grünenthal GmbH (DE) 2001-02-15 WO claimed
EP-1202953-B1 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES GRUENENTHAL GMBH (DE) 2006-08-30 EP disclosed
US-6710080-B2 ANALGESICS GRUENENTHAL GMBH (DE) 2004-03-23 US disclosed
US-20020198251-A1 Substituted 2-dialkylaminoalkylbiphenyl derivatives GRUENENTHAL GMBH (DE) 2002-12-26 US disclosed
EP-1202953-A2 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES Grünenthal GmbH (DE) 2002-05-08 EP disclosed
WO-2001010816-A2 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES Grünenthal GmbH (DE) 2001-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198251-A1 Substituted 2-dialkylaminoalkylbiphenyl derivatives LIPA, PKD1, PKD2 CYP1A2 272/4885CYP2D6 60/4885CYP3A4 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.